Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report.

Caputo, Roberta; Pagliuca, Martina; Pensabene, Matilde; Parola, Sara; De Laurentiis, Michelino

Caputo, Roberta; Pagliuca, Martina; Pensabene, Matilde; Parola, Sara; De Laurentiis, Michelino.

Afiliación

Caputo R; Division of Breast Oncology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
Pagliuca M; Clinical and Translational Oncology, Scuola Superiore Meridionale (SSM), Naples, Italy.
Pensabene M; U981 Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.
Parola S; Division of Breast Oncology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
De Laurentiis M; Unità Operativa Oncologia del PO di San Felice a Cancello, Caserta, Italy.

Front Oncol ; 13: 1214660, 2023.

Article en En | MEDLINE | ID: mdl-37601649

Palabras clave

BRCA mutation; PARP inhibitor; advanced breast cancer; immunotherapy; triple negative breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google